FindTrial
Sign In

COMPARES trial

Combined Paravertebral and Erector Spinae Block for Mastectomy with LD Reconstruction Surgery- A Feasibility Study (COMPARES trial) - COMPARES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057119
Enrollment
10
Registered
2023-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Ultrasoung guided Combined Paravertebral and erector spinae plane block injection: 20 ml of 0.2% ropivacaine (local anaesthetic) will be injected in the paravertebral space and another

Sponsors

Tata Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients, scheduled for mastectomy with LD reconstruction surgery for breast cancer

Exclusion criteria

Exclusion criteria: BMI >30 Coagulopathy or thrombocytopenia Skin conditions- dermatitis, infection etc. Known allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
Pain score (NRS 0-10)Timepoint: 9:00 AM on postoperative day 1—

Secondary

MeasureTime frame
Perioperative requirement of rescue analgesics Pain score (NRS 0-10) at- immediately after (0), at 4 hrs & 8 hrs after emergence from anaesthesia, pain score at discharge from hospital Postopertive nausea and vomiting Length of stay Degree of residual pain on first follow-up (3 days from surgery)Timepoint: immediately after (0), at 4 hrs & 8 hrs after emergence from anaesthesia, pain score at discharge from hospital—

Countries

India

Contacts

Public ContactArunangshu Chakraborty

Tata Medical Center

dr.arunangshu@gmail.com8910324933

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026